今日VC

venture capital & Private Equity

Entries for the ‘公司报道’ Category

Dow Announces Formation of Pfenex Inc. – A New Independent Company That Will Enable Rapid, Cost Effective Production of Recombinant Proteins

MIDLAND, Mich. & NEW YORK, December 7, 2009– The Dow Chemical Company (NYSE: DOW) today announced that it has formed a new independent company that will be known as Pfenex Inc.1 through its Dow Venture Capital group. The new company, headquartered in San Diego, California, is based on human health applications of a Dow-developed technology [...]

Integrated Diagnostics Launches With Pre-Eminent Team and Investors

Dr. Leroy Hood-Led Venture Secures $30 Million Series A Financing From InterWest Partners, Wellcome Trust and dievini
SEATTLE, WA, October 14, 2009– Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated [...]

仲伟志孟雷陈海等离职创业“远见传播” 获2000万天使投资

综合新浪网易等报道,《经济观察报》执行总编仲伟志、《经济观察报》社论委员会召集人首席评论员《观察家》主编孟雷、《中国新闻周刊》执行副主编陈海、中科招商投资管理公司执行副总裁卞华舵等日前已经从各自单位离职,创立了一家名为北京远见文化传播的公司,并且已经拿到了2000万元的天使投资,投资方是山西一家从事传统制造业的企业。
据仲伟志撰文称他们要做一个中国领先的商业文化传媒机构,“这将是一个新型文化传播平台,它摆脱了传统营利模式的单一化与局限性。在期刊图书出版、商帮价值开发、网络传媒运营、区域经济策划、商业旅行服务等领域,“我们将有明显的差异化表现”。
仲同时透露,远见传播的第一阶段,将运营一本新型杂志,建设一个新型智库,构造一个新型电子商务平台。据网易科技报道,杂志的名称暂定为《商业地理》,融合了商业、人文和时尚。仲伟志表示这本杂志将在2010年元旦正式推出为月刊形式。这本杂志将不会从产业(财经、科技)的角度,而是从地理、探索等角度去写商业故事

仲伟志简介:
《经济观察报》执行总编辑,长期致力于经济变革与社会变迁方面的报道与评论。曾任《齐鲁周刊》副总编辑、《财富时报》执行总编辑、《经济观察报》首席记者。
孟雷简介:
《经济观察报》社论委员会召集人、首席评论员、《观察家》主编、社论版主编,首都青记协理事。曾任《经济促进报》(后更名《财富时报》)副总编辑。
陈海简介:
《中国新闻周刊》执行副主编,致力于时政新闻及调查类报道十数年。曾供职于《南方周末》、《南方人物周刊》等知名媒体,系中山大学传播与设计学院特聘教授(新闻系)。
卞华舵简介:
中科招商投资管理公司执行副总裁、厚德九州投资咨询公司董事长、清华大学继续教育学院客座教授。曾任远东控股集团副总裁、江苏人民广播电台和南京人民广播电台专题节目主持人。

Micromet Announces Pricing of Public Offering of Common Stock

BETHESDA, Md., July 30, 2009– Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the pricing of its public offering of 14,000,000 shares of its common stock at a public offering price of $5.00 per share. All of the shares are being [...]

IntelGenx Technologies Corp. Announces $4.5 Million Special Warrants Financing

IntelGenx Technologies Corp. (“IntelGenx” or the “Company”) (TSX VENTURE:IGX)(OTCBB:IGXT) is pleased to announce that it has entered into an agreement with a syndicate of dealers comprising Paradigm Capital Inc., which will lead the syndicate, Union Securities Ltd. and Bolder Investment Partners, Ltd. (the “Agents”), to complete an offering of Special Warrants by way of private [...]